Validation pour Ingenuity226

vers la météo de la validation par utilisateur

Ingenuity226

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 18 - PMID ?

In female adult SP missing a ovary , subcutaneous injection of NODE protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A1">Analyse 1

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A2">Analyse 2

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A3">Analyse 3

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A4">Analyse 4

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A5">Analyse 5

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A6">Analyse 6

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A7">Analyse 7

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A8">Analyse 8

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A9">Analyse 9

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A10">Analyse 10

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A11">Analyse 11

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A12">Analyse 12

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A13">Analyse 13

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A14">Analyse 14

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A15">Analyse 15

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A16">Analyse 16

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A17">Analyse 17

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A18">Analyse 18

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A19">Analyse 19

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A20">Analyse 20

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A21">Analyse 21

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A22">Analyse 22

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A23">Analyse 23

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A24">Analyse 24

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A25">Analyse 25

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A26">Analyse 26

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A27">Analyse 27

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A28">Analyse 28

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A29">Analyse 29

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A30">Analyse 30

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A31">Analyse 31

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A32">Analyse 32

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A33">Analyse 33

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A34">Analyse 34

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A35">Analyse 35

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A36">Analyse 36

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A37">Analyse 37

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A38">Analyse 38

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A39">Analyse 39

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A40">Analyse 40

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A41">Analyse 41

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A42">Analyse 42

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A43">Analyse 43

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A44">Analyse 44

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A45">Analyse 45

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A46">Analyse 46

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A47">Analyse 47

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A48">Analyse 48

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A49">Analyse 49

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A50">Analyse 50

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A51">Analyse 51

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A52">Analyse 52

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A53">Analyse 53

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A54">Analyse 54

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A55">Analyse 55

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A56">Analyse 56

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A57">Analyse 57

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A58">Analyse 58

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A59">Analyse 59

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A60">Analyse 60

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A61">Analyse 61

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A62">Analyse 62

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A63">Analyse 63

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A64">Analyse 64

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A65">Analyse 65

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A66">Analyse 66

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A67">Analyse 67

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A68">Analyse 68

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A69">Analyse 69

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A70">Analyse 70

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A71">Analyse 71

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A72">Analyse 72

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A73">Analyse 73

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A74">Analyse 74

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A75">Analyse 75

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A76">Analyse 76

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A77">Analyse 77

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A78">Analyse 78

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A79">Analyse 79

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A80">Analyse 80

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A81">Analyse 81

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A82">Analyse 82

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A83">Analyse 83

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A84">Analyse 84

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A85">Analyse 85

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A86">Analyse 86

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A87">Analyse 87

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A88">Analyse 88

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A89">Analyse 89

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A90">Analyse 90

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A91">Analyse 91

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A92">Analyse 92

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A93">Analyse 93

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A94">Analyse 94

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A95">Analyse 95

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A96">Analyse 96

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A97">Analyse 97

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A98">Analyse 98

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A99">Analyse 99

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A100">Analyse 100

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A101">Analyse 101

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A102">Analyse 102

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A103">Analyse 103

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A104">Analyse 104

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A105">Analyse 105

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A106">Analyse 106

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A107">Analyse 107

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A108">Analyse 108

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A109">Analyse 109

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A110">Analyse 110

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A111">Analyse 111

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A112">Analyse 112

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                       
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A113">Analyse 113

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                       
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A114">Analyse 114

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

name="reponse" value="A115">Analyse 115

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)